Stereotactic radioablation for ventricular tachycardia; [Stereotaktische Radioablation von ventrikulären Tachykardien]

Non-invasive stereotactic radioablation of ventricular tachycardia (VT) substrate has been proposed as a novel treatment modality for patients not eligible for catheter-based ablation or in whom this approach has failed. Initial clinical results are promising with good short-term efficacy in VT suppression and tolerable side effects. This article reviews the current clinical evidence for cardiac radioablation and gives an overview of important preclinical and translational results. Practical guidance is provided, and a cardiac radioablation planning and treatment workflow based on expert consensus and the authorsʼ institutional experience is set out. © 2021, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.